Phio Pharmaceuticals Corp Stock Price History
PHIO Stock | USD 2.64 0.00 0.00% |
Below is the normalized historical share price chart for Phio Pharmaceuticals Corp extending back to May 10, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Phio Pharmaceuticals stands at 2.64, as last reported on the 28th of November, with the highest price reaching 2.67 and the lowest price hitting 2.45 during the day.
If you're considering investing in Phio Stock, it is important to understand the factors that can impact its price. As of now, Phio Stock is somewhat reliable. Phio Pharmaceuticals Corp maintains Sharpe Ratio (i.e., Efficiency) of 0.0228, which implies the firm had a 0.0228% return per unit of risk over the last 3 months. We have found twenty-one technical indicators for Phio Pharmaceuticals Corp, which you can use to evaluate the volatility of the company. Please check Phio Pharmaceuticals' Variance of 39.8, coefficient of variation of (3,793), and Risk Adjusted Performance of (0.01) to confirm if the risk estimate we provide is consistent with the expected return of 0.14%.
At this time, Phio Pharmaceuticals' Stock Based Compensation To Revenue is very stable compared to the past year. . At this time, Phio Pharmaceuticals' Price To Sales Ratio is very stable compared to the past year. As of the 28th of November 2024, Price Sales Ratio is likely to grow to 274.78, while Price Earnings Ratio is likely to drop (0.15). Phio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of May 2012 | 200 Day MA 5.1867 | 50 Day MA 3.0725 | Beta 1.465 |
Phio |
Sharpe Ratio = 0.0228
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | PHIO | Huge Risk |
Negative Returns |
Estimated Market Risk
6.27 actual daily | 55 55% of assets are less volatile |
Expected Return
0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Phio Pharmaceuticals is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Phio Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 0.5355 | Enterprise Value Ebitda 0.6124 | Price Sales 48.0082 | Shares Float 547.8 K | Wall Street Target Price 36 |
Phio Pharmaceuticals Stock Price History Chart
There are several ways to analyze Phio Stock price data. The simplest method is using a basic Phio candlestick price chart, which shows Phio Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 17, 2024 | 3.7 |
Lowest Price | November 15, 2024 | 2.21 |
Phio Pharmaceuticals November 28, 2024 Stock Price Synopsis
Various analyses of Phio Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Phio Stock. It can be used to describe the percentage change in the price of Phio Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Phio Stock.Phio Pharmaceuticals Price Action Indicator | 0.08 | |
Phio Pharmaceuticals Price Rate Of Daily Change | 1.00 | |
Phio Pharmaceuticals Accumulation Distribution | 3,516 |
Phio Pharmaceuticals November 28, 2024 Stock Price Analysis
Phio Stock Price History Data
The price series of Phio Pharmaceuticals for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 1.49 with a coefficient of variation of 12.81. The price distribution for the period has arithmetic mean of 2.95. The median price for the last 90 days is 2.93. The company completed stock split (1:9) on 5th of July 2024. Phio Pharmaceuticals Corp had dividends distributed to its stock-holders on 2020-01-15.Open | High | Low | Close | Volume | ||
11/27/2024 | 2.51 | 2.67 | 2.45 | 2.63 | 42,669 | |
11/26/2024 | 2.54 | 2.54 | 2.47 | 2.51 | 8,388 | |
11/25/2024 | 2.57 | 2.57 | 2.42 | 2.45 | 34,495 | |
11/22/2024 | 2.58 | 2.58 | 2.40 | 2.47 | 14,969 | |
11/21/2024 | 2.38 | 2.55 | 2.36 | 2.53 | 32,763 | |
11/20/2024 | 2.55 | 2.55 | 2.27 | 2.38 | 40,928 | |
11/19/2024 | 2.23 | 2.66 | 2.23 | 2.55 | 273,446 | |
11/18/2024 | 2.22 | 2.30 | 2.18 | 2.27 | 15,205 | |
11/15/2024 | 2.45 | 2.45 | 2.17 | 2.21 | 51,030 | |
11/14/2024 | 2.44 | 2.47 | 2.21 | 2.23 | 31,134 | |
11/13/2024 | 2.60 | 2.64 | 2.34 | 2.35 | 24,771 | |
11/12/2024 | 2.61 | 2.70 | 2.55 | 2.56 | 18,870 | |
11/11/2024 | 2.96 | 3.00 | 2.49 | 2.61 | 127,734 | |
11/08/2024 | 3.35 | 3.36 | 2.93 | 2.95 | 45,053 | |
11/07/2024 | 3.30 | 3.70 | 3.07 | 3.25 | 111,592 | |
11/06/2024 | 3.26 | 3.26 | 3.11 | 3.26 | 25,965 | |
11/05/2024 | 3.20 | 3.33 | 3.05 | 3.26 | 24,597 | |
11/04/2024 | 3.18 | 3.21 | 3.07 | 3.21 | 5,346 | |
11/01/2024 | 2.98 | 3.20 | 2.95 | 3.12 | 19,462 | |
10/31/2024 | 3.11 | 3.22 | 2.91 | 2.98 | 34,061 | |
10/30/2024 | 3.35 | 3.35 | 3.06 | 3.15 | 72,801 | |
10/29/2024 | 3.07 | 3.30 | 2.91 | 3.29 | 76,396 | |
10/28/2024 | 2.89 | 3.09 | 2.89 | 3.01 | 10,367 | |
10/25/2024 | 3.00 | 3.04 | 2.71 | 2.91 | 25,771 | |
10/24/2024 | 2.97 | 3.17 | 2.95 | 2.96 | 28,191 | |
10/23/2024 | 3.04 | 3.05 | 2.92 | 2.93 | 25,945 | |
10/22/2024 | 3.16 | 3.29 | 3.04 | 3.13 | 25,607 | |
10/21/2024 | 3.01 | 3.25 | 2.98 | 3.18 | 42,613 | |
10/18/2024 | 2.79 | 3.00 | 2.70 | 2.91 | 77,968 | |
10/17/2024 | 3.21 | 3.33 | 2.65 | 2.65 | 96,178 | |
10/16/2024 | 3.01 | 3.88 | 2.86 | 3.25 | 1,081,462 | |
10/15/2024 | 2.73 | 2.86 | 2.60 | 2.76 | 26,168 | |
10/14/2024 | 2.60 | 2.70 | 2.56 | 2.69 | 11,121 | |
10/11/2024 | 2.58 | 2.70 | 2.42 | 2.68 | 19,574 | |
10/10/2024 | 2.89 | 2.92 | 2.53 | 2.55 | 94,779 | |
10/09/2024 | 2.90 | 2.99 | 2.80 | 2.89 | 14,438 | |
10/08/2024 | 3.00 | 3.04 | 2.73 | 2.81 | 30,224 | |
10/07/2024 | 3.08 | 3.17 | 2.65 | 2.89 | 532,872 | |
10/04/2024 | 3.17 | 3.26 | 3.08 | 3.08 | 36,572 | |
10/03/2024 | 3.18 | 3.28 | 3.16 | 3.16 | 14,924 | |
10/02/2024 | 3.41 | 3.47 | 3.15 | 3.18 | 23,893 | |
10/01/2024 | 3.41 | 3.61 | 3.38 | 3.40 | 15,721 | |
09/30/2024 | 3.61 | 3.74 | 3.45 | 3.45 | 31,779 | |
09/27/2024 | 3.57 | 3.61 | 3.46 | 3.50 | 20,276 | |
09/26/2024 | 3.39 | 3.57 | 3.35 | 3.57 | 44,516 | |
09/25/2024 | 3.42 | 3.61 | 3.32 | 3.35 | 44,537 | |
09/24/2024 | 3.55 | 3.55 | 3.33 | 3.42 | 18,069 | |
09/23/2024 | 3.56 | 3.67 | 3.42 | 3.43 | 30,828 | |
09/20/2024 | 3.52 | 3.69 | 3.46 | 3.52 | 37,911 | |
09/19/2024 | 3.48 | 3.70 | 3.45 | 3.55 | 70,440 | |
09/18/2024 | 3.74 | 4.00 | 3.41 | 3.66 | 187,334 | |
09/17/2024 | 3.31 | 3.95 | 3.04 | 3.70 | 210,831 | |
09/16/2024 | 3.36 | 3.39 | 3.09 | 3.31 | 68,011 | |
09/13/2024 | 2.88 | 3.47 | 2.87 | 3.29 | 112,893 | |
09/12/2024 | 2.80 | 2.90 | 2.79 | 2.90 | 7,690 | |
09/11/2024 | 2.82 | 2.91 | 2.74 | 2.79 | 5,425 | |
09/10/2024 | 2.70 | 2.98 | 2.70 | 2.92 | 3,895 | |
09/09/2024 | 2.86 | 2.86 | 2.62 | 2.77 | 3,961 | |
09/06/2024 | 2.87 | 2.87 | 2.50 | 2.61 | 17,600 | |
09/05/2024 | 2.60 | 2.75 | 2.60 | 2.63 | 6,435 | |
09/04/2024 | 2.61 | 2.66 | 2.59 | 2.60 | 8,851 |
About Phio Pharmaceuticals Stock history
Phio Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Phio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Phio Pharmaceuticals Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Phio Pharmaceuticals stock prices may prove useful in developing a viable investing in Phio Pharmaceuticals
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 231.5 K | 243.1 K | |
Net Loss | -15.3 M | -16 M |
Phio Pharmaceuticals Quarterly Net Working Capital |
|
Phio Pharmaceuticals Stock Technical Analysis
Phio Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
All Next | Launch Module |
Phio Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Phio Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Phio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Phio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.01) | |||
Jensen Alpha | (0.30) | |||
Total Risk Alpha | (1.17) | |||
Treynor Ratio | (0.17) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phio Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (14.81) | Return On Assets (0.61) | Return On Equity (1.27) |
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.